Found 26 hits with Last Name = 'angelini' and Initial = 'a' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of casein |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of bovine serum albumin |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 54 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of casein and mouse serum albumin |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of ovalbumin |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Urokinase-type plasminogen activator
(Homo sapiens (Human)) | BDBM50399330
(CHEMBL2180877)Show SMILES [#6]-[#6](-[#6])-[#6@@H]-1-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6@H](-[#6]-c2ccc(-[#8])cc2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c2cc3-[#6]-[#16]-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6])-[#7]-[#6](=O)-[#6@H](-[#6]-[#8])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6](=O)-[#6@H](-[#6]-[#16]-[#6]-c(c3)c2)-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6]-1=O)-[#6](=O)-[#7]-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@H](-[#6])-[#7] |r| Show InChI InChI=1S/C77H119N27O24S3/c1-36(2)60-74(128)99-49(24-59(113)114)69(123)103-54-35-131-32-42-21-40(30-129-33-52(65(119)89-25-55(79)108)102-62(116)38(4)92-70(124)50(28-105)94-57(110)27-90-63(117)44(8-5-17-86-75(80)81)93-56(109)26-91-64(118)45(95-72(54)126)9-6-18-87-76(82)83)20-41(22-42)31-130-34-53(101-61(115)37(3)78)73(127)100-51(29-106)71(125)96-46(10-7-19-88-77(84)85)66(120)98-48(23-39-11-13-43(107)14-12-39)68(122)97-47(67(121)104-60)15-16-58(111)112/h11-14,20-22,36-38,44-54,60,105-107H,5-10,15-19,23-35,78H2,1-4H3,(H2,79,108)(H,89,119)(H,90,117)(H,91,118)(H,92,124)(H,93,109)(H,94,110)(H,95,126)(H,96,125)(H,97,122)(H,98,120)(H,99,128)(H,100,127)(H,101,115)(H,102,116)(H,103,123)(H,104,121)(H,111,112)(H,113,114)(H4,80,81,86)(H4,82,83,87)(H4,84,85,88)/t37-,38-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Inhibition of human uPA using H-Glu-Gly-Arg-pNA as substrate after 1 hr in presence of casein and human serum albumin |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Albumin
(Oryctolagus cuniculus) | BDBM50611553
(CHEMBL5270284) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611555
(CHEMBL5282767) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 6.60E+3 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611556
(CHEMBL5269304) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611557
(CHEMBL5267643) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 1.56E+3 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Mus musculus) | BDBM50611556
(CHEMBL5269304) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611558
(CHEMBL5270477) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611559
(CHEMBL5287247) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 108 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Mus musculus) | BDBM50611559
(CHEMBL5287247) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 118 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611559
(CHEMBL5287247) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611557
(CHEMBL5267643) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 467 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Rattus norvegicus) | BDBM50611557
(CHEMBL5267643) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 266 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Oryctolagus cuniculus) | BDBM50611557
(CHEMBL5267643) | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Mus musculus) | BDBM50611557
(CHEMBL5267643) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Rattus norvegicus) | BDBM50611554
(CHEMBL5275396) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 780 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Rattus norvegicus) | BDBM50611553
(CHEMBL5270284) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611554
(CHEMBL5275396) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 168 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50611553
(CHEMBL5270284) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Rattus norvegicus) | BDBM50611557
(CHEMBL5267643) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| UniChem
| | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this
Ligand-Target Pair | |
Albumin
(Mus musculus) | BDBM50399329
(CHEMBL2180871)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N[C@@H](CCCCN)C(=O)NCCCCN=[N+]=[N-])C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O |r,wU:16.23,4.4,53.52,62.62,69.68,107.113,82.82,74.125,125.128,133.136,156.161,wD:8.12,2.2,44.43,61.60,114.117,96.98,147.152,164.169,25.24,(24.08,-16.61,;23.75,-18.12,;24.91,-19.14,;26.37,-18.67,;24.58,-20.65,;23.12,-21.12,;21.98,-20.09,;22.29,-18.58,;20.51,-20.57,;20.19,-22.07,;21.33,-23.1,;21.01,-24.61,;22.8,-22.63,;19.37,-19.53,;17.9,-20.01,;17.59,-21.51,;16.76,-18.98,;17.08,-17.48,;18.54,-16.99,;18.87,-15.49,;20.33,-15.02,;20.65,-13.52,;19.5,-12.48,;22.12,-13.04,;15.29,-19.46,;14.15,-18.43,;14.47,-16.92,;15.92,-16.44,;16.24,-14.94,;15.1,-13.91,;15.41,-12.41,;12.69,-18.9,;12.37,-20.41,;11.54,-17.88,;10.08,-18.36,;8.93,-17.33,;7.47,-17.81,;6.32,-16.79,;4.86,-17.26,;3.77,-16.17,;2.68,-15.08,;25.72,-21.68,;25.4,-23.18,;27.19,-21.2,;28.33,-22.23,;28.01,-23.73,;29.16,-24.77,;28.84,-26.27,;27.37,-26.74,;29.98,-27.31,;29.8,-21.75,;30.12,-20.25,;30.93,-22.79,;32.4,-22.31,;32.72,-20.81,;34.19,-20.34,;35.33,-21.36,;34.51,-18.83,;33.55,-23.34,;33.22,-24.84,;35.01,-22.87,;36.15,-23.9,;35.83,-25.41,;36.98,-26.43,;34.37,-25.88,;34.05,-27.38,;37.61,-23.42,;37.94,-21.92,;38.76,-24.45,;40.22,-23.98,;40.55,-22.47,;39.4,-21.44,;41.24,-11.03,;42.57,-11.81,;43.91,-11.04,;45.25,-11.83,;45.23,-13.36,;43.89,-14.12,;46.56,-14.14,;46.55,-15.67,;47.88,-16.46,;49.22,-15.69,;47.87,-18,;46.44,-18.56,;45.23,-17.6,;45.29,-16.07,;43.86,-15.53,;42.9,-16.73,;41.36,-16.83,;40.66,-18.2,;41.52,-19.49,;43.06,-19.39,;43.75,-18.01,;49.07,-18.95,;48.85,-20.47,;47.42,-21.04,;50.06,-21.43,;51.48,-20.87,;51.71,-19.34,;53.14,-18.78,;53.37,-17.26,;54.8,-16.7,;56,-17.65,;55.03,-15.17,;49.82,-22.96,;48.5,-23.73,;48.5,-25.26,;47.17,-22.96,;47.01,-21.42,;45.5,-21.11,;44.74,-22.44,;45.76,-23.58,;45.45,-25.09,;46.59,-26.12,;43.98,-25.57,;43.66,-27.06,;44.8,-28.1,;44.48,-29.6,;46.26,-27.63,;42.83,-24.53,;41.36,-25.01,;41.05,-26.51,;43.92,-9.5,;45.26,-8.74,;42.59,-8.73,;42.61,-7.19,;41.28,-6.41,;39.93,-7.17,;38.61,-6.4,;39.93,-8.72,;43.94,-6.42,;43.95,-4.89,;45.27,-7.21,;46.61,-6.44,;46.62,-4.9,;47.95,-4.15,;49.35,-4.77,;50.39,-3.64,;49.63,-2.3,;50.12,-.85,;49.09,.31,;47.58,-.02,;47.09,-1.46,;48.12,-2.62,;47.93,-7.22,;47.93,-8.76,;49.27,-6.45,;50.6,-7.24,;50.59,-8.78,;51.91,-9.55,;51.91,-11.09,;53.24,-11.87,;50.57,-11.86,;51.94,-6.47,;51.94,-4.93,;53.27,-7.26,;54.6,-6.49,;54.61,-4.95,;55.95,-4.19,;57.28,-4.97,;55.96,-2.66,;55.93,-7.27,;55.92,-8.81,;57.27,-6.5,;58.6,-7.28,;58.59,-8.83,;59.91,-9.59,;59.91,-11.14,;61.25,-8.84,;59.93,-6.52,;61.26,-7.3,;59.94,-4.98,)| Show InChI InChI=1S/C109H167N31O30S2/c1-11-58(9)88(137-99(161)72(43-56(5)6)128-92(154)67(29-21-38-117-108(111)112)123-66(28-17-18-36-110)90(152)116-37-19-20-40-122-139-115)104(166)127-70(33-35-84(144)145)95(157)133-76(48-86(148)149)100(162)138-89(59(10)12-2)105(167)136-80-54-172-171-53-79(124-82(141)52-121-91(153)73(45-60-50-119-64-26-15-13-24-62(60)64)130-93(155)68(30-22-39-118-109(113)114)126-103(165)81-31-23-41-140(81)106(168)77(44-57(7)8)134-102(80)164)101(163)129-71(42-55(3)4)96(158)131-74(46-61-51-120-65-27-16-14-25-63(61)65)97(159)125-69(32-34-83(142)143)94(156)132-75(47-85(146)147)98(160)135-78(107(169)170)49-87(150)151/h13-16,24-27,50-51,55-59,66-81,88-89,119-120,123H,11-12,17-23,28-49,52-54,110H2,1-10H3,(H,116,152)(H,121,153)(H,124,141)(H,125,159)(H,126,165)(H,127,166)(H,128,154)(H,129,163)(H,130,155)(H,131,158)(H,132,156)(H,133,157)(H,134,164)(H,135,160)(H,136,167)(H,137,161)(H,138,162)(H,142,143)(H,144,145)(H,146,147)(H,148,149)(H,150,151)(H,169,170)(H4,111,112,117)(H4,113,114,118)/t58-,59-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,88-,89-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Binding affinity to mouse serum albumin by fluorescence polarization assay |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Albumin
(Homo sapiens (Human)) | BDBM50399329
(CHEMBL2180871)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N[C@@H](CCCCN)C(=O)NCCCCN=[N+]=[N-])C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O |r,wU:16.23,4.4,53.52,62.62,69.68,107.113,82.82,74.125,125.128,133.136,156.161,wD:8.12,2.2,44.43,61.60,114.117,96.98,147.152,164.169,25.24,(24.08,-16.61,;23.75,-18.12,;24.91,-19.14,;26.37,-18.67,;24.58,-20.65,;23.12,-21.12,;21.98,-20.09,;22.29,-18.58,;20.51,-20.57,;20.19,-22.07,;21.33,-23.1,;21.01,-24.61,;22.8,-22.63,;19.37,-19.53,;17.9,-20.01,;17.59,-21.51,;16.76,-18.98,;17.08,-17.48,;18.54,-16.99,;18.87,-15.49,;20.33,-15.02,;20.65,-13.52,;19.5,-12.48,;22.12,-13.04,;15.29,-19.46,;14.15,-18.43,;14.47,-16.92,;15.92,-16.44,;16.24,-14.94,;15.1,-13.91,;15.41,-12.41,;12.69,-18.9,;12.37,-20.41,;11.54,-17.88,;10.08,-18.36,;8.93,-17.33,;7.47,-17.81,;6.32,-16.79,;4.86,-17.26,;3.77,-16.17,;2.68,-15.08,;25.72,-21.68,;25.4,-23.18,;27.19,-21.2,;28.33,-22.23,;28.01,-23.73,;29.16,-24.77,;28.84,-26.27,;27.37,-26.74,;29.98,-27.31,;29.8,-21.75,;30.12,-20.25,;30.93,-22.79,;32.4,-22.31,;32.72,-20.81,;34.19,-20.34,;35.33,-21.36,;34.51,-18.83,;33.55,-23.34,;33.22,-24.84,;35.01,-22.87,;36.15,-23.9,;35.83,-25.41,;36.98,-26.43,;34.37,-25.88,;34.05,-27.38,;37.61,-23.42,;37.94,-21.92,;38.76,-24.45,;40.22,-23.98,;40.55,-22.47,;39.4,-21.44,;41.24,-11.03,;42.57,-11.81,;43.91,-11.04,;45.25,-11.83,;45.23,-13.36,;43.89,-14.12,;46.56,-14.14,;46.55,-15.67,;47.88,-16.46,;49.22,-15.69,;47.87,-18,;46.44,-18.56,;45.23,-17.6,;45.29,-16.07,;43.86,-15.53,;42.9,-16.73,;41.36,-16.83,;40.66,-18.2,;41.52,-19.49,;43.06,-19.39,;43.75,-18.01,;49.07,-18.95,;48.85,-20.47,;47.42,-21.04,;50.06,-21.43,;51.48,-20.87,;51.71,-19.34,;53.14,-18.78,;53.37,-17.26,;54.8,-16.7,;56,-17.65,;55.03,-15.17,;49.82,-22.96,;48.5,-23.73,;48.5,-25.26,;47.17,-22.96,;47.01,-21.42,;45.5,-21.11,;44.74,-22.44,;45.76,-23.58,;45.45,-25.09,;46.59,-26.12,;43.98,-25.57,;43.66,-27.06,;44.8,-28.1,;44.48,-29.6,;46.26,-27.63,;42.83,-24.53,;41.36,-25.01,;41.05,-26.51,;43.92,-9.5,;45.26,-8.74,;42.59,-8.73,;42.61,-7.19,;41.28,-6.41,;39.93,-7.17,;38.61,-6.4,;39.93,-8.72,;43.94,-6.42,;43.95,-4.89,;45.27,-7.21,;46.61,-6.44,;46.62,-4.9,;47.95,-4.15,;49.35,-4.77,;50.39,-3.64,;49.63,-2.3,;50.12,-.85,;49.09,.31,;47.58,-.02,;47.09,-1.46,;48.12,-2.62,;47.93,-7.22,;47.93,-8.76,;49.27,-6.45,;50.6,-7.24,;50.59,-8.78,;51.91,-9.55,;51.91,-11.09,;53.24,-11.87,;50.57,-11.86,;51.94,-6.47,;51.94,-4.93,;53.27,-7.26,;54.6,-6.49,;54.61,-4.95,;55.95,-4.19,;57.28,-4.97,;55.96,-2.66,;55.93,-7.27,;55.92,-8.81,;57.27,-6.5,;58.6,-7.28,;58.59,-8.83,;59.91,-9.59,;59.91,-11.14,;61.25,-8.84,;59.93,-6.52,;61.26,-7.3,;59.94,-4.98,)| Show InChI InChI=1S/C109H167N31O30S2/c1-11-58(9)88(137-99(161)72(43-56(5)6)128-92(154)67(29-21-38-117-108(111)112)123-66(28-17-18-36-110)90(152)116-37-19-20-40-122-139-115)104(166)127-70(33-35-84(144)145)95(157)133-76(48-86(148)149)100(162)138-89(59(10)12-2)105(167)136-80-54-172-171-53-79(124-82(141)52-121-91(153)73(45-60-50-119-64-26-15-13-24-62(60)64)130-93(155)68(30-22-39-118-109(113)114)126-103(165)81-31-23-41-140(81)106(168)77(44-57(7)8)134-102(80)164)101(163)129-71(42-55(3)4)96(158)131-74(46-61-51-120-65-27-16-14-25-63(61)65)97(159)125-69(32-34-83(142)143)94(156)132-75(47-85(146)147)98(160)135-78(107(169)170)49-87(150)151/h13-16,24-27,50-51,55-59,66-81,88-89,119-120,123H,11-12,17-23,28-49,52-54,110H2,1-10H3,(H,116,152)(H,121,153)(H,124,141)(H,125,159)(H,126,165)(H,127,166)(H,128,154)(H,129,163)(H,130,155)(H,131,158)(H,132,156)(H,133,157)(H,134,164)(H,135,160)(H,136,167)(H,137,161)(H,138,162)(H,142,143)(H,144,145)(H,146,147)(H,148,149)(H,150,151)(H,169,170)(H4,111,112,117)(H4,113,114,118)/t58-,59-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,88-,89-/m0/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | 321 | n/a | n/a | n/a | n/a | n/a |
Ecole Polytechnique F�d�rale de Lausanne
Curated by ChEMBL
| Assay Description
Binding affinity to human serum albumin by fluorescence polarization assay |
J Med Chem 55: 10187-97 (2012)
Article DOI: 10.1021/jm301276e
BindingDB Entry DOI: 10.7270/Q25140CZ |
More data for this
Ligand-Target Pair | |
Search and Browse
